Public Health

Most Americans agree with the CDC and FDA's pause on Johnson & Johnson's one-dose COVID-19 vaccine as the agencies review cases of rare but serious blood clots in people who've received the shot, according to an Axios/Ipsos poll published April…

Researchers at Texas A&M University in College Station have identified a new coronavirus variant, according to an April 19 news release.

Researchers from New York City-based Weill Cornell Medicine are testing a prescription video game to see if it can help with memory loss and attention problems after recovery from COVID-19, according to an April 19 report by The Verge.

Colorado is on the verge of a fourth COVID-19 surge as cases and hospitalizations rise, officials said. At the same time, the state has relaxed some of its pandemic safety regulations, The New York Times reported April 18. 

The nation has watched as COVID-19 cases, hospitalizations and deaths surge in Michigan, which experts believe may be due, in part, to a high level of variant spread. 

The seven-day average number of COVID-19 vaccines administered daily was 3.3 million as of April 15, a 10.3 percent increase from the previous week's average, according to the CDC's COVID Data Tracker Weekly Review published April 16. 

Early research estimates have shown anywhere between 10 percent to 30 percent of people with COVID-19 go on to become long-haulers, or those who experience persistent symptoms weeks or months after the infection has cleared. With more than 31.2 million…

All states reported minimal flu activity for the 11th consecutive week, excluding Washington, D.C., which reported insufficient data, according to the CDC's FluView report for the week ending April 10.

The CDC is urging public health powers to improve HIV prevention and treatment for transgender women, according to a National HIV Behavioral Surveillance report published in April. 

Millions of Americans have immune systems weakened by certain diseases, cancer therapies and other factors, leaving them unable to produce an adequate level of COVID-19 antibodies after a prior infection or after vaccination, The New York Times reported April 15.